Study for regulating reactive T cells against allograft and tumor

Development of novel allo- or tumor-reactive T cell analyzing assay and exploring novel approach to manipulate T cell response - Development of novel allo- or tumor-reactive T cell analyzing assay and exploring novel approach to manipulate T cell response

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039682

Enrollment

Registered

2020-03-04

Start date

2020-03-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Organ transplantation Malignant tumor

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Available informed consent from identical person

Exclusion criteria

Exclusion criteria: 1, The person with regular hospital visit 2, THe person who have a axiuos about thier health. 3, The person with weight less than 40kg. 4, the person who did blood donation within 1 month. 5, The person possibly be pregnant. 6, The person has a history of infectious disease within a week. 7, The person who has a direct interst with the investigators, like teacher and student. 8, The person who is recognized as inappropriate for the candidate by investigators.

Design outcomes

Primary

Measure	Time frame
Frequency of antigen specific T cell in allo and tumor specific stimulation	—

Countries

Japan

Contacts

Public ContactNaoki Tanimine

Hiroshima University Hospital Department of Gstroenterological and Transplant Surgery

tanimine@hiroshima-u.ac.jp082-257-5220

Outcome results